Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes
Open Access
- 1 February 2015
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 28 (2) , 248-260
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Right-sided rhabdoid colorectal tumors might be related to the Serrated PathwayDiagnostic Pathology, 2013
- Combined Loss of E-cadherin and Aberrant β-Catenin Protein Expression Correlates With a Poor Prognosis for Small Intestinal AdenocarcinomasAmerican Journal of Clinical Pathology, 2013
- A Multicenter Study to Validate the Reproducibility of MSI Testing With a Panel of 5 Quasimonomorphic Mononucleotide RepeatsDiagnostic Molecular Pathology, 2010
- Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS, BRAF, NRAS and PIK3CA GenesPLOS ONE, 2010
- Anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor: a case reportJournal of Medical Case Reports, 2008
- Giant‐cell containing neoplasms of the pancreas: An aspiration cytology studyDiagnostic Cytopathology, 2008
- Anaplastic carcinoma of the pancreas with rhabdoid features and hyaline globule-like structuresMedical Molecular Morphology, 2007
- Immunohistochemistry of INI1 Expression: A New Tool for Old Challenges in CNS and Soft Tissue PathologyAdvances in Anatomic Pathology, 2007
- Mutation of the INI1 gene in composite rhabdoid tumor of the endometriumHuman Pathology, 2007
- SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid featuresPathology International, 2006